With the exception of ETS2, JUN and ZBTB16, the expression of most of these transcription factors was upregulated (average changes greater than 1.2-fold) in HBV-related HCC, compared with non-HCC (Supplementary Table S12). This evidence concerns the gene ETS2 and hepatocellular carcinoma.